Mr. Whitfield: Quite simply, Incyte has produced and distributes the world's largest and most comprehensive database of genomic information. We work with 19 of the top 20 pharmaceutical companies, an increasing number of the biotechnology companies, and now through the Internet, academic researchers worldwide.
TWST: What do you see as the most significant trends or developments in
the field of genomics?
Mr. Whitfield: The need to integrate all the various types of genomic
information. Genomics has moved rapidly in the last couple of years from
beyond sequence information and the simple type of information you get
from the human genome project, to more detailed and valuable types of
genomic information, like gene expression data, proteomic information,
information on genetic variation. All this information is much closer to
the ultimate biology and solution to diseases, but is much more complex
and needs greater horsepower from an information processing point of
view. We're in the lead in all of that, so the whole strategy is to be
out in front in all of those developments.
Tickers included in this excerpt: INCY
For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.